Pryor et al. found that IMP-3 was expressed in melanomas but not in benign nevi, even when dysplastic features were present and IMP-3 was expressed in metastatic melanomas significantly more than in thin melanomas [4]. This evidence concerns the gene IMP3 and metastatic melanoma.